Switch to:

Denali Therapeutics Other Current Liabilities

: $11.0 Mil (As of Sep. 2019)
View and export this data going back to 2017. Start your Free Trial

Denali Therapeutics's other current liabilities for the quarter that ended in Sep. 2019 was $11.0 Mil.

Denali Therapeutics's quarterly other current liabilities increased from Mar. 2019 ($4.3 Mil) to Jun. 2019 ($6.2 Mil) and increased from Jun. 2019 ($6.2 Mil) to Sep. 2019 ($11.0 Mil).

Denali Therapeutics's annual other current liabilities increased from Dec. 2016 ($2.8 Mil) to Dec. 2017 ($5.2 Mil) and increased from Dec. 2017 ($5.2 Mil) to Dec. 2018 ($10.3 Mil).


Denali Therapeutics Other Current Liabilities Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Other Current Liabilities 0.00 0.00 0.00 0.00

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Other Current Liabilities Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Denali Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Denali Therapeutics Other Current Liabilities Related Terms


Denali Therapeutics Other Current Liabilities Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */